JAGUAR HEALTH, INC. (JAGX) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$7.12M*; Operating income -$7.60M; Depreciation and amortization $473.00K*.
- 2026-03-31: Basis Reported; EBITDA $10.66M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$20.77M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$6.76M*; Operating income -$7.24M; Depreciation and amortization $479.00K*.
Complete source-backed ebitda history.
- Available history
- 2015-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$7.12M* | -$7.60M | $473.00K* | (m) | (m) | (m) | -$5.34M* | (m) | $3.34M | (m) | $0.00 |
|---|
| 2026-03-31 | Reported | $10.66M | (m) | (m) | (m) | 52.56% | (m) | $8.83M | (m) | $3.93M | (m) | $0.00 |
|---|
| 2025-12-31 | Reported | -$20.77M | (m) | (m) | (m) | -641.89% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$6.76M* | -$7.24M | $479.00K* | (m) | (m) | (m) | -$4.69M* | $0.00* | $3.66M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$7.53M* | -$8.01M | $478.00K* | (m) | (m) | (m) | -$6.20M* | $97.00K | $3.27M | (m) | $0.00 |
|---|
| 2025-03-31 | Reported | -$8.94M | (m) | (m) | (m) | -403.88% | (m) | -$7.31M | (m) | $3.73M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$7.68M | (m) | (m) | (m) | -218.84% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$6.79M* | -$7.26M | $474.00K* | (m) | (m) | $0.00* | -$6.34M* | (m) | $4.04M | (m) | $0.00* |
|---|
| 2024-06-30 | Reported | -$6.75M* | -$7.20M | $447.00K* | (m) | (m) | (m) | -$8.17M* | (m) | $3.65M | (m) | $0.00 |
|---|
| 2024-03-31 | Reported | -$7.71M | (m) | (m) | (m) | -328.12% | (m) | -$7.05M | (m) | $4.31M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$7.06M | (m) | (m) | (m) | -306.74% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$8.28M* | -$8.79M | $504.00K* | (m) | (m) | $0.00* | -$6.79M* | (m) | $6.08M | (m) | $0.00 |
|---|
| 2023-06-30 | Reported | -$7.60M* | -$8.10M | $503.00K* | (m) | (m) | $0.00* | -$9.06M* | (m) | $4.28M | (m) | $0.00 |
|---|
| 2023-03-31 | Reported | -$9.34M | (m) | (m) | (m) | (m) | $0.00 | -$9.95M | (m) | $4.78M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$5.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$9.40M* | -$9.90M | $498.00K* | (m) | (m) | $3.00K* | -$8.53M* | (m) | $5.94M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$5.92M* | -$6.48M | $558.00K* | (m) | (m) | (m) | -$10.46M* | (m) | $2.45M | (m) | (m) |
|---|
| 2022-03-31 | Reported | -$11.33M | (m) | (m) | (m) | (m) | (m) | -$7.70M | (m) | $4.95M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$10.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$9.10M* | -$9.53M | $429.00K* | (m) | (m) | $0.00* | -$9.43M* | (m) | $3.31M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$11.15M* | -$11.58M | $430.00K* | (m) | (m) | (m) | -$9.91M* | (m) | $3.87M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$8.34M | (m) | (m) | (m) | (m) | (m) | -$6.71M | (m) | $2.41M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$4.74M | (m) | (m) | (m) | -183.85% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$4.94M* | -$5.38M | $433.00K* | (m) | (m) | $0.00* | -$2.92M* | (m) | $1.52M | (m) | (m) |
|---|
| 2020-06-30 | Reported | -$8.02M* | -$8.45M | $431.00K* | (m) | (m) | $0.00* | -$4.00M* | (m) | $1.41M | (m) | (m) |
|---|
| 2020-03-31 | Reported | -$7.22M | (m) | (m) | (m) | -831.07% | $7.00K | -$4.30M | (m) | $1.58M | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$5.39M | (m) | (m) | (m) | -357.80% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | -$6.29M* | -$6.73M | $432.00K* | (m) | (m) | (m) | -$8.55M* | (m) | $1.31M | (m) | $10.00K |
|---|
| 2019-06-30 | Reported | -$10.19M* | -$10.62M | $436.00K* | (m) | (m) | (m) | -$5.30M* | (m) | $1.70M | (m) | (m) |
|---|
| 2019-03-31 | Reported | -$5.34M | (m) | (m) | (m) | -335.72% | (m) | -$3.46M | (m) | $1.42M | (m) | (m) |
|---|
| 2018-12-31 | Reported | -$11.78M | (m) | (m) | (m) | -738.19% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-09-30 | Reported | -$6.18M* | -$6.51M | $329.89K* | (m) | (m) | $0.00* | -$2.81M* | (m) | $1.48M | (m) | (m) |
|---|
| 2018-06-30 | Reported | -$6.75M* | -$7.08M | $329.67K* | $883.85K | -763.64%* | $0.00* | -$5.40M* | (m) | $1.60M | (m) | (m) |
|---|
| 2018-03-31 | Reported | -$4.8M | (m) | (m) | (m) | -596.59% | $6.53K | -$9.62M | (m) | $757.87K | (m) | (m) |
|---|
| 2017-12-31 | Reported | -$20.42M | (m) | (m) | (m) | -1324.41% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2017-09-30 | Reported | -$7.04M | (m) | (m) | (m) | -640.23% | (m) | -$3.03M* | (m) | $851.61K | (m) | -$12.19M |
|---|
| 2017-06-30 | Reported | -$2.34M | (m) | (m) | (m) | -260.48% | (m) | -$1.18M* | (m) | $926.79K | (m) | (m) |
|---|
| 2017-03-31 | Reported | -$3.86M | (m) | (m) | (m) | -469.42% | (m) | -$288.72K | (m) | $1.26M | (m) | (m) |
|---|
| 2016-12-31 | Reported | -$3.3M | (m) | (m) | (m) | -11424.37% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2016-09-30 | Reported | -$3.16M | (m) | (m) | (m) | -6282.73% | $5.94K* | -$3.38M* | (m) | $1.97M | (m) | (m) |
|---|
| 2016-06-30 | Reported | -$3.4M | (m) | (m) | (m) | -14077.79% | $12.54K* | (m) | (m) | $1.95M | (m) | (m) |
|---|
| 2016-03-31 | Reported | -$3.68M | (m) | (m) | (m) | -9638.97% | $85.72K | (m) | (m) | $1.75M | (m) | (m) |
|---|
| 2015-09-30 | Reported | (m) | -$2.75M | (m) | (m) | (m) | (m) | (m) | (m) | $1.24M | (m) | (m) |
|---|
| 2015-06-30 | Reported | (m) | -$3.17M | (m) | (m) | (m) | (m) | (m) | (m) | $1.75M | (m) | (m) |
|---|
| 2015-03-31 | Reported | (m) | -$2.68M | (m) | (m) | (m) | (m) | (m) | (m) | $1.42M | (m) | (m) |
|---|
| 2014-09-30 | Reported | (m) | -$2.58M | (m) | (m) | (m) | $0.00* | (m) | (m) | $1.13M | (m) | (m) |
|---|
| 2014-06-30 | Reported | (m) | -$1.94M | (m) | (m) | (m) | (m) | (m) | (m) | $691.18K | (m) | (m) |
|---|
| 2014-03-31 | Reported | (m) | -$1.95M | (m) | (m) | (m) | (m) | (m) | (m) | $1.46M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$44M | (m) | (m) | (m) | -382.20% | (m) | -$23.69M | $97.00K | $24.97M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$28.93M | (m) | (m) | (m) | -247.51% | $16.00K | -$29.38M | (m) | $16.54M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$32.28M | (m) | (m) | (m) | -330.68% | (m) | -$33.24M | (m) | $18.60M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$32.43M | (m) | (m) | (m) | -271.28% | $77.00K | -$33.10M | (m) | $17.65M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$38.99M | (m) | (m) | (m) | -899.40% | $6.00K | -$34.97M | (m) | $15.08M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$24.92M | (m) | (m) | (m) | -265.53% | $7.00K | -$15.28M | (m) | $6.41M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$27.21M | (m) | (m) | (m) | -471.19% | (m) | -$20.46M | (m) | $5.82M | (m) | $10.00K |
|---|
| 2018-12-31 | Reported | -$29.5M | (m) | (m) | (m) | -668.12% | $6.53K | -$22.73M | (m) | $5.15M | (m) | (m) |
|---|
| 2017-12-31 | Reported | -$33.66M | (m) | (m) | (m) | -771.87% | (m) | -$9.82M | (m) | $4.27M | (m) | -$13.18M |
|---|
| 2016-12-31 | Reported | -$13.54M | (m) | (m) | (m) | -9566.28% | $104.21K | -$14.41M | (m) | $7.21M | (m) | (m) |
|---|
| 2015-12-31 | Reported | -$12.44M | (m) | (m) | (m) | -4814.68% | $23.30K | (m) | (m) | $6.48M | (m) | (m) |
|---|
| 2014-12-31 | Reported | (m) | -$8.32M | (m) | (m) | (m) | $55.15K | (m) | (m) | $4.22M | (m) | (m) |
|---|